1 | 1 | | 85R3192 MEW-D |
---|
2 | 2 | | By: Creighton S.B. No. 270 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to health benefit plan coverage for abuse-deterrent opioid |
---|
8 | 8 | | analgesic drugs. |
---|
9 | 9 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
10 | 10 | | SECTION 1. Chapter 1369, Insurance Code, is amended by |
---|
11 | 11 | | adding Subchapter J to read as follows: |
---|
12 | 12 | | SUBCHAPTER J. COVERAGE FOR ABUSE-DETERRENT OPIOID ANALGESIC DRUGS |
---|
13 | 13 | | Sec. 1369.451. DEFINITIONS. In this subchapter: |
---|
14 | 14 | | (1) "Abuse-deterrent opioid analgesic drug" means an |
---|
15 | 15 | | opioid analgesic drug that the United States Food and Drug |
---|
16 | 16 | | Administration has approved and for which the United States Food |
---|
17 | 17 | | and Drug Administration has approved abuse-deterrence labeling |
---|
18 | 18 | | that indicates the drug is expected to result in a meaningful |
---|
19 | 19 | | reduction in abuse. |
---|
20 | 20 | | (2) "Opioid analgesic drug" means a drug in the opioid |
---|
21 | 21 | | analgesic drug class that: |
---|
22 | 22 | | (A) is prescribed to treat moderate to severe |
---|
23 | 23 | | pain or other conditions; and |
---|
24 | 24 | | (B) may be: |
---|
25 | 25 | | (i) in an immediate-release or |
---|
26 | 26 | | extended-release form of the drug; |
---|
27 | 27 | | (ii) a single component drug; or |
---|
28 | 28 | | (iii) in combination with another drug. |
---|
29 | 29 | | Sec. 1369.452. APPLICABILITY OF SUBCHAPTER. (a) This |
---|
30 | 30 | | subchapter applies only to a health benefit plan that provides |
---|
31 | 31 | | benefits for medical or surgical expenses incurred as a result of a |
---|
32 | 32 | | health condition, accident, or sickness, including an individual, |
---|
33 | 33 | | group, blanket, or franchise insurance policy or insurance |
---|
34 | 34 | | agreement, a group hospital service contract, or an individual or |
---|
35 | 35 | | group evidence of coverage or similar coverage document that is |
---|
36 | 36 | | offered by: |
---|
37 | 37 | | (1) an insurance company; |
---|
38 | 38 | | (2) a group hospital service corporation operating |
---|
39 | 39 | | under Chapter 842; |
---|
40 | 40 | | (3) a fraternal benefit society operating under |
---|
41 | 41 | | Chapter 885; |
---|
42 | 42 | | (4) a stipulated premium company operating under |
---|
43 | 43 | | Chapter 884; |
---|
44 | 44 | | (5) a reciprocal exchange operating under Chapter 942; |
---|
45 | 45 | | (6) a health maintenance organization operating under |
---|
46 | 46 | | Chapter 843; |
---|
47 | 47 | | (7) a multiple employer welfare arrangement that holds |
---|
48 | 48 | | a certificate of authority under Chapter 846; or |
---|
49 | 49 | | (8) an approved nonprofit health corporation that |
---|
50 | 50 | | holds a certificate of authority under Chapter 844. |
---|
51 | 51 | | (b) Notwithstanding Section 1501.251 or any other law, this |
---|
52 | 52 | | subchapter applies to a small employer health benefit plan subject |
---|
53 | 53 | | to Chapter 1501. |
---|
54 | 54 | | (c) Notwithstanding any other law, a standard health |
---|
55 | 55 | | benefit plan provided under Chapter 1507 must provide the coverage |
---|
56 | 56 | | required by this subchapter. |
---|
57 | 57 | | Sec. 1369.453. EXCEPTIONS. (a) This subchapter does not |
---|
58 | 58 | | apply to: |
---|
59 | 59 | | (1) a health benefit plan that provides coverage only: |
---|
60 | 60 | | (A) for a specified disease or for another |
---|
61 | 61 | | limited benefit other than for cancer; |
---|
62 | 62 | | (B) for accidental death or dismemberment; |
---|
63 | 63 | | (C) for wages or payments in lieu of wages for a |
---|
64 | 64 | | period during which an employee is absent from work because of |
---|
65 | 65 | | sickness or injury; |
---|
66 | 66 | | (D) as a supplement to a liability insurance |
---|
67 | 67 | | policy; |
---|
68 | 68 | | (E) for credit insurance; |
---|
69 | 69 | | (F) for dental or vision care; or |
---|
70 | 70 | | (G) for indemnity for hospital confinement; |
---|
71 | 71 | | (2) a Medicare supplemental policy as defined by |
---|
72 | 72 | | Section 1882(g)(1), Social Security Act (42 U.S.C. Section 1395ss); |
---|
73 | 73 | | (3) a workers' compensation insurance policy; |
---|
74 | 74 | | (4) medical payment insurance coverage provided under |
---|
75 | 75 | | a motor vehicle insurance policy; or |
---|
76 | 76 | | (5) a long-term care insurance policy, including a |
---|
77 | 77 | | nursing home fixed indemnity policy, unless the commissioner |
---|
78 | 78 | | determines that the policy provides benefit coverage so |
---|
79 | 79 | | comprehensive that the policy is a health benefit plan as described |
---|
80 | 80 | | by Section 1369.452. |
---|
81 | 81 | | (b) This subchapter does not apply to: |
---|
82 | 82 | | (1) the Medicaid managed care program operated under |
---|
83 | 83 | | Chapter 533, Government Code; |
---|
84 | 84 | | (2) the Medicaid program operated under Chapter 32, |
---|
85 | 85 | | Human Resources Code; or |
---|
86 | 86 | | (3) the child health plan program operated under |
---|
87 | 87 | | Chapter 62, Health and Safety Code. |
---|
88 | 88 | | Sec. 1369.454. REQUIRED COVERAGE FOR ABUSE-DETERRENT |
---|
89 | 89 | | OPIOID ANALGESIC DRUGS. (a) A health benefit plan must provide |
---|
90 | 90 | | coverage for abuse-deterrent opioid analgesic drugs. |
---|
91 | 91 | | (b) A health benefit plan issuer may not reduce or limit a |
---|
92 | 92 | | payment to a health care professional, or otherwise penalize the |
---|
93 | 93 | | professional, because the professional prescribes or dispenses an |
---|
94 | 94 | | abuse-deterrent opioid analgesic drug. |
---|
95 | 95 | | Sec. 1369.455. PRIOR AUTHORIZATION. (a) A health benefit |
---|
96 | 96 | | plan may require prior authorization for an abuse-deterrent opioid |
---|
97 | 97 | | analgesic drug in the same manner that the health benefit plan |
---|
98 | 98 | | requires prior authorization for an opioid analgesic drug that does |
---|
99 | 99 | | not have abuse-deterrent properties. |
---|
100 | 100 | | (b) A health benefit plan may not require an enrollee to use |
---|
101 | 101 | | an opioid analgesic drug that does not have abuse-deterrent |
---|
102 | 102 | | properties before prior authorization for an abuse-deterrent |
---|
103 | 103 | | opioid analgesic drug may be given. |
---|
104 | 104 | | SECTION 2. Subchapter J, Chapter 1369, Insurance Code, as |
---|
105 | 105 | | added by this Act, applies only to a health benefit plan that is |
---|
106 | 106 | | delivered, issued for delivery, or renewed on or after January 1, |
---|
107 | 107 | | 2018. A health benefit plan that is delivered, issued for delivery, |
---|
108 | 108 | | or renewed before January 1, 2018, is covered by the law as it |
---|
109 | 109 | | existed immediately before the effective date of this Act, and that |
---|
110 | 110 | | law is continued in effect for that purpose. |
---|
111 | 111 | | SECTION 3. This Act takes effect September 1, 2017. |
---|